While a lower-dose Semaglutide formulation (Ozempic) is primarily indicated for Type 2 diabetes management, Wegovy's suitability in patients with both Type 2 diabetes and obesity is a clinical decision that must be made by your physician after assessing the full clinical picture
He remained on 5 mg weekly for 6 months before moving to his final dose of 7.5 mg weekly
Candidacy depends on your goals, your skin and hair concerns, your medical history, and any medications or conditions that could interact with a peptide protocol
Nerve-related issues like numbness, tingling sensations, muscle weakness, or difficulties in walking
GLP-1 Shots is the active receptor agonist in weight loss injections like Ozempic, Rybelsus and Wegovy
The Next Frontier of Regenerative Medicine Peptide therapy at Prefusion Health is never delivered in isolation